Medibank (ASX:MPL) share price up as customers get millions in support

Medibank is giving some of the money it's saved during COVID-19 lockdowns back to its customers. We take a closer look

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Medibank Private Ltd (ASX: MPL) recovered from a poor start this morning following news the company will be returning around $105 million to its customers.

At the time of writing, the Medibank share price is $3.16 – 0.48% higher than its previous close.

For comparison, the S&P/ASX 200 Index (ASX: XJO) is down 0.67% right now.

Let's take a look at today's news from the healthcare and health insurance company.

elderly woman cheers in doctor's office

Image source: Getty Images

Medibank's COVID-19 support

Medibank has announced it will be returning $105 million in COVID-19 net claims savings. Around 2 million of its customers will be eligible for the give back.

Medibank customers with extras-only policies will receive up to $52, while those holding hospital and extras policies could get $175.

It will also be postponing premium increases for 6 months.

Additionally, ahm customer extra limits will be extended by a year as many customers couldn't use their extras during COVID-19 lockdowns.

The give back will be funded through a partial release of the savings Medibank made when customers were forced to defer their claims because of COVID-19.

Australian Medibank and ahm customers who held policies between 1 July 2020 and 30 June 2021 are eligible for the support. Most customers will receive the financial support by the end of September.

The company has now handed out $300 million worth of COVID-19 support.

Medibank doesn't expect COVID-19 to impact its operating earnings for the 2021 financial year.

Commentary from management

Medibank's CEO David Koczkar said of the company's financial support package:

We've been there for our customers to help them navigate through this challenging time, and this give back is just another example of how we are supporting our customers…

We said right from the start of the pandemic that we would not profit from COVID-19, and that we were committed to returning any COVID-19 savings back to our customers because it is the right thing to do. And today's announcement shows that we have done what we said we would.

Medibank Private share price snapshot

Lately, the Medibank share price has been performing well on the ASX. It's currently 4% higher than it was at the start of 2021. It has also gained 7% since this time last year.

The company has a market capitalisation of around $8.6 billion, with approximately 2.7 billion shares outstanding.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Researchers and doctors with futuristic 3d hologram overlay for body anatomy or dna in hospital clinic.
Healthcare Shares

Are investors taking a big gamble chasing 4DX shares higher and higher?

Investor interest in this ASX healthcare tech stock is booming.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

Half a man's face from the nose up peers over a table.
Healthcare Shares

If I could buy only 1 ASX 200 share right now, it would be…

This stock looks underpriced and oversold to me.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

CSL shares slide again in March — but is a comeback brewing?

Brokers remain upbeat and see upside up to 95% for the biotech stock.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.
Healthcare Shares

Is it time to get greedy with CSL shares?

This ASX healthcare giant is out of favour, but that may be where opportunity starts.

Read more »

Stressed, unhappy, and tired scientist with a headache working on a computer in a lab.
Healthcare Shares

3 ASX 200 healthcare shares at multi-year lows

Does this present a buying opportunity?

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »